Antibody Responses in Aging SIV Infected Monkeys

感染 SIV 的衰老猴子的抗体反应

基本信息

  • 批准号:
    9120783
  • 负责人:
  • 金额:
    $ 81.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-05 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This proposal aims to understand the impact of a pathogenic lentivirus infection on the immune system in aging, a physiologic state of immune impairment. This question is significant in that it addresses a critical public health issue, given that numbers of people with HIV over age 50 is on the rise due to both, dramatic efficacy of potent combination antiretroviral therapy (cART) and increasing incidence of new HIV infections in the aging population, It is well established that robustness of vaccine -induced immune responses are a powerful tool for elucidating level of immune competence and a useful model for investigating mechanisms of immune dysfunction. Our studies with peripheral blood from HIV infected people on cART have indicated that Ab responses to seasonal influenza vaccine are impaired with aging and are associated with increased immune activation and defective function of a CD4 subset designated as peripheral T follicular helper cells (pTfh) jn blood. A subset of these cells are believed to be functionally similar to germinal center (GC) Tfh that provide critical help to B cells for differentiating into antibody producing cells, but the relatioship of pTfh to GC Tfh and Tfh traffic from blood to lymphoid tissue has not been conclusively established. Based on our findings we hypothesize that 1. Aging is associated with functional deficiency of Tfh that leads to impaired vaccine responses and 2. These defects are made worse by HIV infection despite virologic control with cART and 3. Immune activation exacerbates Tfh dysfunction. The Tfh-B cell interaction can only be answered through study of lymphoid tissue which is most feasible in rhesus macaques. Our team has special expertise in in situ analyses of lymph nodes that will enable us to investigate Tfh and B cell interaction in situ. . We will compare young and old SIV infected macaques with controlled viremia for their responses to seasonal influenza and tetanus vaccines for T-dependent immune responses to study neo and recall antibody responses. SIV uninfected RM will serve as controls. We will investigate the mechanisms of impaired vaccine responses by characterization of total and antigen-specific Tfh and B cells by phenotype, cellular function and gene transcription studies in cells from lymph nodes and peripheral blood. In situ immunohistology and histo- cytometry studies will provide novel insights into the impact of aging and that of aging complicated by SIV infection on Tfh and B cells in GC. We will study if cells with Tfh phenotype traffic to LN in association with booster vaccination. We will define more precisely the role of underlying inflammation and immune activation in perpetuating immune dysfunction and identify predictive immune signatures of vaccine responsiveness. Subcutaneous injections of interleukin 21 (the signature Tfh cytokine) will be investigated as a modality to augment vaccine responses. These findings have relevance for HIV infected aging population.
 描述(由申请方提供):该提案旨在了解致病性慢病毒感染对衰老免疫系统的影响,这是一种免疫损伤的生理状态。这个问题的重要性在于它涉及一个关键的公共卫生问题, 50岁以上的HIV感染者的数量正在增加,这是由于有效的联合抗逆转录病毒疗法(cART)的显著疗效和老龄人口中新的HIV感染的发病率增加。已经充分确定,疫苗诱导的免疫应答的稳健性是阐明免疫能力水平的有力工具和研究免疫功能障碍机制的有用模型。我们对来自接受cART的HIV感染者的外周血的研究表明,对季节性流感疫苗的Ab应答随着年龄的增长而受损,并且与血液中指定为外周T滤泡辅助细胞(pTfh)的CD 4亚群的免疫活化增加和功能缺陷相关。这些细胞的一个亚群被认为在功能上类似于生发中心(GC)Tfh,其为B细胞分化成抗体产生细胞提供关键帮助,但是pTfh与GC Tfh和Tfh从血液到淋巴组织的运输的关系尚未最终确定。根据我们的研究结果,我们假设1。衰老与Tfh的功能缺陷有关,导致疫苗应答受损;尽管用cART进行了病毒学控制,但HIV感染使这些缺陷变得更糟。免疫激活加剧了Tfh功能障碍。Tfh-B细胞相互作用只能通过淋巴组织的研究来回答,这在恒河猴中是最可行的。我们的团队在淋巴结的原位分析方面具有特殊的专业知识,这将使我们能够原位研究Tfh和B细胞的相互作用。.我们将比较年轻和年老的SIV感染猕猴与控制病毒血症的反应,季节性流感和破伤风疫苗的T依赖性免疫反应,研究新的和回忆抗体反应。SIV未感染RM将作为对照。我们将通过淋巴结和外周血细胞中的表型、细胞功能和基因转录研究,对总Tfh和B细胞和抗原特异性Tfh和B细胞进行表征,研究疫苗应答受损的机制。原位免疫组织学和组织细胞学研究将为衰老和衰老并发SIV感染对胃癌中Tfh和B细胞的影响提供新的见解。我们将研究Tfh表型的细胞是否与加强疫苗接种相关地运输到LN。我们将更精确地定义潜在炎症和免疫激活在维持免疫功能障碍中的作用,并确定疫苗反应性的预测性免疫特征。将研究皮下注射白细胞介素21(标志性Tfh细胞因子)作为增强疫苗应答的方式。这些发现对HIV感染的老年人群具有相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Savita Pahwa其他文献

Savita Pahwa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Savita Pahwa', 18)}}的其他基金

Immune Dysfunction in HIV+ Opioid Users
HIV 阿片类药物使用者的免疫功能障碍
  • 批准号:
    10343782
  • 财政年份:
    2020
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Dysfunction in HIV + Opiod Users
HIV阿片使用者的免疫功能障碍
  • 批准号:
    10381164
  • 财政年份:
    2020
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Dysfunction in HIV + Opiod Users
HIV阿片使用者的免疫功能障碍
  • 批准号:
    10845088
  • 财政年份:
    2020
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Dysfunction in HIV+ Opioid Users
HIV 阿片类药物使用者的免疫功能障碍
  • 批准号:
    10001242
  • 财政年份:
    2020
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Dysfunction in HIV + Opiod Users
HIV阿片使用者的免疫功能障碍
  • 批准号:
    10552153
  • 财政年份:
    2020
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune correlates of LTBI in HIV-exposed infants
HIV 暴露婴儿 LTBI 的免疫相关性
  • 批准号:
    10543401
  • 财政年份:
    2019
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immunity and HIV persistence in perinatal HIV infection
围产期 HIV 感染中的免疫和 HIV 持续性
  • 批准号:
    9211649
  • 财政年份:
    2016
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immunity and HIV persistence in perinatal HIV infection
围产期 HIV 感染中的免疫和 HIV 持续性
  • 批准号:
    9302666
  • 财政年份:
    2016
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Activation in Virologically Suppressed Indian HIV-infected Patients
病毒学受到抑制的印度艾滋病毒感染者的免疫激活
  • 批准号:
    8540075
  • 财政年份:
    2013
  • 资助金额:
    $ 81.46万
  • 项目类别:
Immune Activation in Virologically Suppressed Indian HIV-infected Patients
病毒学受到抑制的印度艾滋病毒感染者的免疫激活
  • 批准号:
    8728729
  • 财政年份:
    2013
  • 资助金额:
    $ 81.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 81.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了